Ian Sacks - 23 Jun 2022 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Delano W. Ladd, Attorney-in-Fact
Issuer symbol
HQY
Transactions as of
23 Jun 2022
Transactions value $
$0
Form type
4
Filing time
27 Jun 2022, 19:50:14
Previous filing
23 Jun 2022
Next filing
22 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Award $0 +3K +2.02% $0.00 152K 23 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 15K 23 Jun 2022 Common Stock 15K $21.27 Direct F2
holding HQY Stock Option (right to buy) 15K 23 Jun 2022 Common Stock 15K $14.00 Direct F2
holding HQY Stock Option (right to buy) 15K 23 Jun 2022 Common Stock 15K $25.39 Direct F2
holding HQY Stock Option (right to buy) 8.02K 23 Jun 2022 Common Stock 8.02K $66.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's next annual stockholder meeting, which is expected to be held in June of 2023. Vested shares will be delivered to the reporting person upon vesting.
F2 The option is immediately exercisable.

Remarks:

The power of Attorney given by Ms. McCowan was previously filed with the U.S. Securities and Exchange Commission on April 3, 2018 as an exhibit to a statement on Form 3 filed by Ms. McCowan with respect to HealthEquity, Inc. and is hereby incorporated by reference.